Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
168M
-
Shares change
-
+9.5M
-
Total reported value, excl. options
-
$6.54B
-
Value change
-
+$376M
-
Put/Call ratio
-
0.53
-
Number of buys
-
118
-
Number of sells
-
-83
-
Price
-
$38.81
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q2 2024
259 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q2 2024.
Revolution Medicines, Inc. - Common Stock (RVMD) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 168M shares
of 186M outstanding shares and own 90.64% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14.4M shares), WELLINGTON MANAGEMENT GROUP LLP (13.7M shares), BlackRock Inc. (13.4M shares), FARALLON CAPITAL MANAGEMENT LLC (9.76M shares), BAKER BROS. ADVISORS LP (7.57M shares), Nextech Invest Ltd. (6.3M shares), BVF INC/IL (5.98M shares), FMR LLC (5.63M shares), Alphabet Inc. (5.31M shares), and Paradigm Biocapital Advisors LP (5.26M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.